MindMaze Therapeutics (SIX: MMTX) has announced the appointment of health tech veteran Zach Henderson as chief executive officer (CEO).
With more than 30 years of experience scaling healthcare technology platforms and driving significant recurring revenue growth, Mr. Henderson most recently served as CEO of Rune Labs.
In a statement, Walid Hanna, chairman of the board at MindMaze, commented, “MindMaze has built the industry’s most rigorous clinical foundation. Our mission now is to translate that scientific leadership into widespread market adoption. Zach’s operation depth and success across global markets make him the ideal leader to drive our commercial expansion and deliver value to our shareholders.”
